Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of allergic conditions
3.2.1.2 Advancements in sublingual dosage immunotherapy
3.2.1.3 Expanding product portfolio
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of treatment
3.2.2.2 Limited awareness and accessibility
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Subcutaneous immunotherapy (SCIT)
5.3 Sublingual immunotherapy (SLIT)
5.3.1 Tablets
5.3.2 Drops
Chapter 6 Market Estimates and Forecast, By Allergy Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Allergic rhinitis
6.3 Asthma
6.4 Skin allergy
6.5 Food allergy
6.6 Other allergies
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospital pharmacy
7.3 Retail pharmacy
7.4 Online pharmacy
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Adamis Pharmaceuticals Corporation
9.2 Aimmune Therapeutics, Inc.
9.3 ALK-Abelló A/S
9.4 Allergy Therapeutics plc
9.5 ASIT Biotech
9.6 Circassia Pharmaceuticals plc
9.7 DESENTUM OY
9.8 DVB Technologies SA
9.9 HAL Allergy B.V.
9.10 HollisterStier Allergy
9.11 LETI Pharma
9.12 Merck KGaA
9.13 Mylan N.V.
9.14 Stallergenes Greer plc
9.15 Zhejiang Wolwo Bio-pharmaceutical Co., Ltd.
